IT1391251B1 - COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES - Google Patents

COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES

Info

Publication number
IT1391251B1
IT1391251B1 ITMI2008A001829A ITMI20081829A IT1391251B1 IT 1391251 B1 IT1391251 B1 IT 1391251B1 IT MI2008A001829 A ITMI2008A001829 A IT MI2008A001829A IT MI20081829 A ITMI20081829 A IT MI20081829A IT 1391251 B1 IT1391251 B1 IT 1391251B1
Authority
IT
Italy
Prior art keywords
treatment
composition
articular diseases
articular
diseases
Prior art date
Application number
ITMI2008A001829A
Other languages
Italian (it)
Inventor
Dino Benetti
Maico Polzella
Original Assignee
Innovative Nutrition & Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovative Nutrition & Pharma Srl filed Critical Innovative Nutrition & Pharma Srl
Priority to ITMI2008A001829A priority Critical patent/IT1391251B1/en
Publication of ITMI20081829A1 publication Critical patent/ITMI20081829A1/en
Application granted granted Critical
Publication of IT1391251B1 publication Critical patent/IT1391251B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4172Imidazole-alkanecarboxylic acids, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/505Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/428Vitamins, e.g. tocopherol, riboflavin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ITMI2008A001829A 2008-10-15 2008-10-15 COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES IT1391251B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI2008A001829A IT1391251B1 (en) 2008-10-15 2008-10-15 COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI2008A001829A IT1391251B1 (en) 2008-10-15 2008-10-15 COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES

Publications (2)

Publication Number Publication Date
ITMI20081829A1 ITMI20081829A1 (en) 2010-04-16
IT1391251B1 true IT1391251B1 (en) 2011-12-01

Family

ID=40636695

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI2008A001829A IT1391251B1 (en) 2008-10-15 2008-10-15 COMPOSITION FOR THE TREATMENT OF ARTICULAR DISEASES

Country Status (1)

Country Link
IT (1) IT1391251B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700110784A1 (en) * 2017-10-03 2019-04-03 Fidia Farm Spa Pharmaceutical compositions containing Hyaluronic acid and Carnosine and its use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61186322A (en) * 1985-02-13 1986-08-20 Nippon Univ Immunomodulator
IT1281876B1 (en) * 1995-05-10 1998-03-03 Fidia Advanced Biopolymers Srl HYALURONIC ACID AND ITS ESTER DERIVATIVES FOR THE PREPARATION OF MATRIXES FOR THE CONTROLLED RELEASE OF DRUGS.
DE10111165A1 (en) * 2001-03-02 2002-10-10 Knoell Hans Forschung Ev Use of hyaluronic acid uronides for the treatment of inflammatory processes
DE10246340A1 (en) * 2002-10-04 2004-04-29 Wohlrab, David, Dr. Combination preparation of hyaluronic acid and at least one local anesthetic and its use

Also Published As

Publication number Publication date
ITMI20081829A1 (en) 2010-04-16

Similar Documents

Publication Publication Date Title
CY2020032I2 (en) PLEUROMUTILIN DERIVATIVES FOR THE TREATMENT OF DISEASES CAUSED BY MICROBES
BRPI1012116A2 (en) pharmaceutical composition for the treatment of heart disease
BRPI0908026A2 (en) Methods for the treatment of bowel diseases
SMAP200900085A (en) 3-imidazolyl-indoles for the treatment of malolysiseproliferative
SMT201600055B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OR PREVENTION OF GLAUCOMA
DK2504005T3 (en) USE OF 1,3-DIPHENYLPROP-2-ONE-1-DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES
IL200368A0 (en) Treatment of diseases characterized by inflammation
IL208357A0 (en) Spiro-indole derivatives for the treatment of parasitic diseases
IT1391866B1 (en) INJECTIONABLE COMPOSITION OF POLYNUCLEOTIDS FOR THE TREATMENT OF OSTEOARTICULAR DISEASES.
HK1141447A1 (en) Pharmaceutical composition for the treatment of proliferative diseases
BR112012004836A2 (en) pyrazinylpyridines useful for the treatment of proliferative diseases
IL211313A0 (en) Compounds, compositions and methods for the treatment of ??-amyloid diseases and synucleinopathies
DK2117565T3 (en) APPLICATION OF CHITOSANES FOR THE TREATMENT OF NON-FLAMMATORY DISEASES
ITRM20050179A1 (en) APPLICABLE COMPOSITION FOR THE TREATMENT OF PARADONTAL DISEASES.
ZA201009072B (en) Pharmaceutical composition for the treatment of premature ejaculation
BRPI0914454A2 (en) "composition for the treatment of epithelial tissue"
ZA200905364B (en) Treatment of diseases characterized by inflammation
BRPI0914139A2 (en) Pediatric compositions for the treatment of multiple sclerosis
IT1397838B1 (en) COMPOSITION FOR TREATMENT OF PLANTS
BRPI0915761A2 (en) heterocyclyl compound for treatment of cardiovascular disease
BRPI0912679A2 (en) pharmaceutical composition for the treatment of fibromyalgia
HK1158954A1 (en) 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
PL2323625T3 (en) New composition for the treatment of ecchymotic pigmentations
IL200753A (en) Pharmaceutical composition comprising ib-meca for the treatment of psoriasis
SMT201300156B (en) Sulfonamide compounds for the treatment of respiratory disorders